• BCA Protein Quantification Kit K4102: Workflow Guide

  2026-09-25

  The Bicinchoninic Acid Assay (BCA) Protein Quantification Kit K4102 measures total protein in dilute samples, including cell lysates and many detergent-containing preparations. Use it for research measurement and sample normalization, not for diagnostic, clinical, or medical testing; check compatibility with the specific sample buffer before relying on results.

• Streptavidin Magnetic Beads: K1301 Workflow

  2026-09-25

  Benzyl-activated Streptavidin Magnetic Beads (SKU: K1301) capture biotinylated targets for magnetic recovery from complex samples, including protein, antibody, peptide, and nucleic-acid workflows. They are appropriate when the target or capture reagent is biotinylated; they are not a direct substitute for non-biotin affinity capture, and preservative and elution compatibility should be checked before cell-based or sensitive downstream assays.

• Separating Growth Arrest from Cell Killing in Cancer

  2026-09-24

  Hannah R. Schwartz’s dissertation shows why relative viability and fractional viability should not be treated as interchangeable measures of anticancer drug response: one combines growth inhibition and cell loss, while the other focuses on killing. The findings support time-aware, complementary measurements that can distinguish cytostatic from cytotoxic effects and sharpen interpretation of in vitro drug studies.

• Nilotinib (AMN-107) Research Workflows

  2026-09-24

  Build reproducible Nilotinib workflows around target engagement—not viability alone—with practical guidance for BCR-ABL, KIT, and exploratory neuronal assays. A 2024 SH-SY5Y study also illustrates why protein-level checks and clear limits on cross-domain interpretation matter.

• DAPI Staining in Tumor NET Research

  2026-09-23

  DAPI staining makes nuclear morphology and DNA distribution visible, but it cannot by itself establish apoptosis or neutrophil extracellular trap formation. This guide explains how to use DAPI in tumor NET research and interpret it alongside mechanistic evidence on PAD4 and histone citrullination.

• DiscoveryProbe FDA-Approved Drug Library

  2026-09-23

  The DiscoveryProbe FDA-approved Drug Library turns clinically annotated chemical space into a phenotype-to-target workflow. Using the HDAC6-focused gastric cancer study as a practical model, this guide explains how to design orthogonal validation, distinguish cytotoxicity from migration effects, and advance credible drug repositioning screening.

• ECL Western Blotting Substrate: Practical Guide

  2026-09-22

  ECL Western Blotting Substrate (SKU K2187) is a luminol-based, nonradioactive horseradish peroxidase detection reagent for Western blot assay workflows, allowing signal capture on X-ray film or CCD cameras. Use it for HRP immunoblots and related protein detection by chemiluminescence; it is not a reagent for fluorescent or radioisotopic detection.

• Beyond Viability: Measuring Drug Responses in Cancer

  2026-09-22

  Hannah R. Schwartz’s dissertation distinguishes relative viability from fractional viability, showing that growth inhibition and cell death are related but non-equivalent features of anticancer drug response. The framework helps researchers interpret timing, potency, and mechanism more accurately by separating cytostatic effects from actual cell killing.

• Etomoxir in Whole-Blood Immunometabolism Research

  2026-09-21

  Etomoxir enables dose-resolved testing of how fatty acid oxidation influences cytokine responses in fresh human whole blood. This practical workflow separates CPT-1-directed effects from higher-dose DGAT activity while improving donor controls, vehicle matching, and translational interpretation.

• ATG9A, PTOV1, and 14-3-3 in Cancer Biology

  2026-09-21

  The reference study identifies ATG9A and PTOV1 as previously uncharacterized 14-3-3-interacting proteins and connects each interaction to a distinct regulatory pathway. Its findings clarify how ATG9A supports basal autophagy and how SGK2-dependent PTOV1 stabilization may promote oncogenic signaling, offering mechanistic targets for further cancer research.

• Benzyl-activated Streptavidin Magnetic Beads

  2026-09-20

  Benzyl-activated Streptavidin Magnetic Beads (SKU: K1301) provide magnetic capture of biotinylated proteins, peptides, antibodies, sugars, oligonucleotides, and nucleic acids from complex samples. They are appropriate for purification, immunoprecipitation, and interaction workflows, but should not be treated as a universal capture reagent for non-biotinylated targets or as evidence of validated performance in a specific biological assay.

• gamma-Glu-Cys: Assays, Peptide Synthesis & Plant Stress

  2026-09-19

  Use gamma-Glu-Cys as a defined substrate for glutathione synthetase enzyme assay development, peptide engineering, and cell-free plant stress studies. Its high solubility, characterized purity, and short-term solution handling requirements support reproducible experiments, while Bacillus research shows why strain and medium must be tested together.

• PRC2 Inhibition Unlocks Chimpanzee Naive PSC Self-Renewal

  2026-09-18

  Huang et al. show that excessive PRC2-mediated H3K27me3 deposition is a barrier to sustained self-renewal of chimpanzee naive pluripotent stem cells. PRC2 inhibition produces cells that resemble human naive PSCs and early epiblast, retain broad developmental competence, and generate tri-lineage blastoids, while also improving feeder-free propagation of human naive PSCs.

• ALC-0315 LNP Workflow for mRNA Delivery

  2026-09-18

  ALC-0315 provides a practical ionizable amino lipid foundation for screening mRNA lipid nanoparticles, from reporter assays to antigen-expression studies. This workflow pairs formulation controls with the staged validation strategy reported in a murine cryptococcosis vaccine study, while keeping exploratory parameters distinct from product specifications.

• ECL Western Blotting Substrate: Workflow Guide

  2026-09-17

  ECL Western Blotting Substrate (SKU K2187) is a luminol-based, nonradioactive horseradish peroxidase detection reagent for generating chemiluminescent signals on immunoblots. It is intended for HRP-based Western blot assays using X-ray film or CCD imaging, not for fluorescent or radioisotopic detection formats.

733 records 1/49 page Next 12345 下5页 Last page